Excelsoft Tech IPO allotment likely to be finalised on November 24. Excelsoft Tech IPO share allotment is likely to be finalised later tonight, November 24, after the issue drew a 43 times ...
Indian stock markets will observe a holiday on Christmas, December 25th, with trading halted across BSE and NSE equity, derivatives, and SLB segments. Normal operations resume on December 26th. This ...
Excelsoft Technologies IPO Allotment Status: The basis of allotment of the IPO shares of Excelsoft Technologies Ltd. is likely to be finalised on Monday, November 24. Investors who have applied for ...
Excelsoft Technologies stock settled with only 5 per cent listing gains on Wednesday despite 15 per cent premium debut over the offer price of ₹120. The stock began trading at ₹135 on the NSE and BSE, ...
Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their ...
Excelsoft Technologies IPO listing date is November 26, and the shares will be listed on BSE and NSE.(Image: Company Website) Excelsoft Technologies IPO Listing: Excelsoft Technologies shares will ...
Shares of Excelsoft Technologies on Wednesday made a decent market debut, listing at a 12.50 per cent premium on the BSE and the National Stock Exchange (NSE), against the issue price of Rs 120. The ...
The growing demand for AI infrastructure creates clear opportunities for this tech industry stalwart. The demand for data center capacity, especially on servers capable of running artificial ...
(Bloomberg) --Trading of futures and options on the Chicago Mercantile Exchange was halted by a data-center fault, causing hours of disruption to markets across equities, foreign exchange, bonds and ...
Equity benchmarks traded continued to trade flat in the mid-trading session session on Friday as traders adopt a wait-and-watch stance ahead of today’s Q2 GDP print. BSE Sensex and NSE Nifty 50 staged ...
Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...